Position in OGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$692,683
-$136,455 QoQ
Shares Held
115,640
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $692,683 | 115,640 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $829,138 | 115,640 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,244,039 | 303,749 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,940,290 | 303,749 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,721,879 | 115,640 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,725,348 | 115,640 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,212,193 | 115,640 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,393,748 | 115,640 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,198,904 | 116,963 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $33,463,324 | 2,320,619 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $62,084,150 | 3,576,276 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $123,869,588 | 5,952,407 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $148,757,600 | 6,324,728 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $335,734,630 | 12,020,574 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $288,202,799 | 12,316,359 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $400,338,010 | 11,861,867 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $397,044,069 | 11,366,850 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $216,572,366 | 7,112,393 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $173,184,352 | 5,281,621 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $12,919,295 | 426,943 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||